Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review

BACKGROUND: High-grade and recurrent meningiomas are often treatment resistant and pose a therapeutic challenge after surgical and radiation therapy (RT) failure. Temozolomide (TMZ) is a DNA alkylating agent that appears to have a radiosensitizing effect when used in combination with RT and may be w...

Descripción completa

Detalles Bibliográficos
Autores principales: Belanger, Katherine, Ung, Timothy H., Damek, Denise, Lillehei, Kevin O., Ormond, D. Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988385/
https://www.ncbi.nlm.nih.gov/pubmed/35392834
http://dx.doi.org/10.1186/s12885-022-09340-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988385/
https://www.ncbi.nlm.nih.gov/pubmed/35392834
http://dx.doi.org/10.1186/s12885-022-09340-7

Ejemplares similares